Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)May 31, 2025 | (FY)May 31, 2024 | (FY)May 31, 2023 | (FY)May 31, 2022 | (FY)May 31, 2021 | |
|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | |||||
| Cash from operating activities | -0.84%495.56M | 69.60%499.77M | 30.50%294.68M | 391.76%225.81M | 45.92M |
| Net profit before non-cash adjustment | 27.42%408.19M | 32.51%320.36M | 287.73%241.77M | 351.72%62.36M | ---24.77M |
| Total adjustment of non-cash items | 77.43%86.65M | 217.15%48.84M | 273.13%15.4M | -2.27%4.13M | --4.22M |
| -Depreciation and amortization | 72.44%83.25M | 228.44%48.28M | 438.82%14.7M | -9.25%2.73M | --3.01M |
| -Disposal profit | --0 | ---197K | --0 | ---- | ---- |
| -Net exchange gains and losses | --2.56M | --0 | ---- | ---- | ---- |
| -Other non-cash items | 11.08%842K | 8.29%758K | -49.96%700K | 14.95%1.4M | --1.22M |
| Changes in working capital | -99.45%719K | 248.13%130.57M | -76.46%37.51M | 139.70%159.33M | --66.47M |
| -Change in receivables | -150.88%-91.51M | 62.70%-36.48M | -210.71%-97.78M | -29.51%-31.47M | ---24.3M |
| -Change in payables | -155.66%-5.65M | -20.05%10.14M | -58.65%12.69M | 86.89%30.68M | --16.42M |
| -Changes in other current assets | -199.58%-163.5M | 12.85%-54.58M | -260.76%-62.62M | 35.37%-17.36M | ---26.86M |
| -Changes in other current liabilities | 23.59%261.37M | 14.18%211.48M | 4.36%185.22M | 75.36%177.47M | --101.21M |
| Dividends paid (cash flow from operating activities) | |||||
| Dividends received (cash flow from operating activities) | |||||
| Interest paid (cash flow from operating activities) | -85.34%-1.42M | -8.37%-764K | 49.75%-705K | -11.35%-1.4M | -1.26M |
| Interest received (cash flow from operating activities) | 9,466.67%574K | 20.00%6K | 25.00%5K | -42.86%4K | 7K |
| Tax refund paid | 3.74%-107.39M | -365.78%-111.56M | -1,344.26%-23.95M | 129.37%1.93M | -6.55M |
| Other operating cash inflow (outflow) | 0.00%-1K | -1K | 0 | 1K | 0 |
| Operating cash flow | -0.03%387.32M | 43.49%387.45M | 19.30%270.03M | 493.88%226.34M | --38.11M |
| Investing cash flow | |||||
| Net PPE purchase and sale | -313.22%-3.38M | 62.83%-817K | ---2.2M | --0 | ---1.08M |
| Net intangibles purchase and sale | -23.87%-190.2M | -25.25%-153.55M | ---122.59M | --0 | ---- |
| Net investment product transactions | ---19.98M | --0 | --50K | --0 | ---- |
| Net changes in other investments | ---1K | ---- | ---1K | ---- | ---- |
| Investing cash flow | -38.34%-213.56M | -23.75%-154.37M | ---124.74M | --0 | ---1.08M |
| Financing cash flow | |||||
| Net issuance payments of debt | -139.12%-49.98M | 373.83%127.76M | 16.01%-46.66M | -166.44%-55.55M | --83.62M |
| Net common stock issuance | -97.11%3.4M | --117.41M | --0 | ---- | ---- |
| Net other fund-raising expenses | --1K | ---- | ---- | ---- | ---455K |
| Financing cash flow | -119.00%-46.58M | 625.48%245.17M | 16.01%-46.66M | -166.80%-55.55M | --83.16M |
| Net cash flow | |||||
| Beginning cash position | 87.11%1.03B | 21.90%549.01M | 61.08%450.39M | 75.40%279.6M | --159.41M |
| Current changes in cash | -73.41%127.18M | 384.91%478.25M | -42.25%98.63M | 42.09%170.78M | --120.2M |
| Effect of exchange rate changes | ---2.56M | --0 | ---- | ---- | ---- |
| Cash adjustments other than cash changes | ---- | 200.00%1K | -200.00%-1K | --1K | ---- |
| End cash Position | 12.13%1.15B | 87.11%1.03B | 21.90%549.01M | 61.08%450.39M | --279.6M |
| Free cash flow | -16.80%193.75M | 60.34%232.87M | -35.83%145.23M | 511.14%226.34M | --37.04M |
| Currency Unit | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |